A synthetic peptide fragment of thymosin beta-4, researched for wound healing and tissue repair.
Artificial cells, nanomedicine, and biotechnology|2018|Yu R et al.|9 citations
Thymosin β4 (Tβ4) is a multifunctional N-acetylated peptide with distinct activities important at various stages. Due to its potential multiple therapeutic uses in many fields, there is an increasing need of Tβ4 at lower costs than with the use of ch…
Animal Study
PMID: 29989423
Pharmacological research|2018|Kumar N, Yin C|50 citations
Cardiovascular diseases (CVDs) represent ∼31% of all global deaths, and hypertension alone accounts for ∼50% of these cases. Inflammation and subsequent fibrosis in heart, kidney and brain are associated with increased morbidity and mortality in CVD…
Review
PMID: 29990624
Scientific reports|2018|Kim C et al.|28 citations
This study evaluated the clinical activity of RGN-259 (thymosin β4) in comparison with cyclosporine A (CsA), diquafosol (DQS), and lifitegrast (LFA) in a murine model of dry eye. The model was NOD.B10-H2mice in a 30-40% humidified environment togethe…
Animal Study
PMID: 30002412
ACS omega|2018|Yoo S et al.|28 citations
Here, we demonstrated chimeric adeno-associated virus (chimeric AAV), AAV-DJ-mediated cardiovascular reprogramming strategy to generate new cardiomyocytes and limit collagen deposition in cardiac fibroblasts by inducing synergism of chimeric AAV-expr…
PMID: 30023931
Expert opinion on biological therapy|2018|Gupta S, Li L|6 citations
INTRODUCTION: Thymosin beta-4 (Tβ4) is an actin sequestering protein and is furthermore involved in diverse biological processes including cell proliferation, differentiation, wound healing, stem- or progenitor cell differentiation, and modulates inf…
ReviewAnimal Study
PMID: 30063846
Hypertension (Dallas, Tex. : 1979)|2018|Kumar N et al.|24 citations
Thymosin β4 (Tβ4), a ubiquitous peptide, regulates several cellular processes that include cell morphology, wound healing, and inflammatory response. Administration of exogenous Tβ4 is protective in diabetic nephropathy and in a unilateral ureteral o…
Animal Study
PMID: 29632102
Expert opinion on biological therapy|2018|Renga G et al.|25 citations
INTRODUCTION: Thymosin β4 (Tβ4) is a thymic hormone with multiple and different intracellular and extracellular activities affecting wound healing, inflammation, fibrosis and tissue regeneration. As the failure to resolve inflammation leads to uncont…
Review
PMID: 30063848
Expert opinion on biological therapy|2018|Dubé K, Smart N|18 citations
INTRODUCTION: Formation of the vasculature is a complex process, defects in which can lead to embryonic lethality or disease in later life. Understanding mechanisms of vasculogenesis may facilitate the treatment of developmental defects and may be ex…
Review
PMID: 30063849
Expert opinion on biological therapy|2018|Pardon M|16 citations
INTRODUCTION: The actin-sequestering thymosin beta4 (Tβ4) is the most abundant member of the β-thymosins, and is widely expressed in the central nervous system (CNS), but its functions in the healthy and diseased brain are poorly understood. The expr…
Review
PMID: 30063850
Expert opinion on biological therapy|2018|Tan W et al.|5 citations
INTRODUCTION: Thymosin beta-4 (TB4) is an endogenous peptide with protective and regenerative effects in models of cellular and organ injury. TB4 is increasingly measured as a potential plasma or serum biomarker in human cardiovascular, liver, infect…
Review
PMID: 29502471
Expert opinion on biological therapy|2018|Shah R, Reyes-Gordillo K, Rojkind M|11 citations
OBJECTIVES: Hepatic stellate cells (HSC) trans-differentiation is central to the development of liver fibrosis, marked by the expression of pro-fibrogenic genes and the proliferation and migration of activated HSC. Therefore, preventing and/or revert…
PMID: 30063851
Expert opinion on biological therapy|2018|Ziegler T, Hinkel R, Kupatt C|1 citation
INTRODUCTION: The establishment of induced pluripotent stem cells (iPSCs) and cardiomyocytes differentiated from them generated a new platform to study pathophysiological processes and to generate drug screening platforms and iPSC-derived tissues as…
Review
PMID: 30063852
Expert opinion on biological therapy|2018|Sosne G|11 citations
Thymosin beta 4 (Tβ4) has important applications in ocular repair and Phase 3 clinical trials using Tβ4 to treat dry eye and neurotrophic keratopathy are currently ongoing. These exciting clinical possibilities for Tβ4 in the eye are the result of se…
Review
PMID: 30063853
International journal of molecular medicine|2018|Ji H et al.|7 citations
Cerebral ischemia causes severe brain injury and results in selective neuronal death through programmed cell death mechanisms, including apoptosis and autophagy. Minimizing neuronal injury has been considered a hot topic among clinicians. The present…
PMID: 29328391
Expert opinion on biological therapy|2018|Hinkel R et al.|10 citations
INTRODUCTION: Despite recent advances in the treatment of coronary heart disease, a significant number of patients progressively develop heart failure. Reduction of infarct size after acute myocardial infarction and normalization of microvasculature…
Review
PMID: 30063857
Expert opinion on biological therapy|2018|Morris D, Zhang Z, Chopp M|5 citations
INTRODUCTION: Thymosin β4 (Tβ4) is a 5K peptide which influences cellular migration by inhibiting organization of the actin-cytoskeleton. Treatment of acute stroke presently involves use of rt-PA and/or endovascular treatment with thrombectomy, both…
ReviewAnimal Study
PMID: 30063858
Expert opinion on biological therapy|2018|Hannappel E, Iavarone F, Castagnola M|2 citations
OBJECTIVES: We reevaluated a lyophilized sample of thymosin fraction 5, stored for 37 years at room temperature, by high-resolution mass spectrometry in terms of stability and yet uncharacterized polypeptides that could be biological important substa…
PMID: 30063862
Oxidative medicine and cellular longevity|2018|Shah R et al.|48 citations
Thymosin beta 4 (T4), an actin-sequestering protein, is involved in tissue development and regeneration. It prevents inflammation and fibrosis in several tissues. We investigated the role of T4 in chronic ethanol- and acute lipopolysaccharide- (LPS-)…
Animal Study
PMID: 30116499
BioMed research international|2018|Cho K et al.|3 citations
Thymosin4 (T4) treatment was known to show the potential therapeutic effects on diabetic complications. This study was performed to determine if T4 expression is changed in both serum and tissues under diabetic conditions and can be a serum biomarker…
Animal Study
PMID: 30225249
International journal of molecular medicine|2018|Choi B et al.|4 citations
Thymosin β4 (Tβ4) regulates the expression of molecules associated with dentinogenesis, including bone sialoprotein (BSP). BSP regulates the initiation of mineralization and the direction of dentin growth. However, the association between Tβ4 signali…
Animal Study
PMID: 30226623